Back
Altamira Therapeutics Ltd. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
CYTOF
Altamira Therapeutics Ltd.
Last Price:
$0.08
Seasonality Move:
5.94%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and CYTOF is experiencing selling pressure, which indicates risk of future bearish movement.
Altamira Therapeutics Ltd. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.08 | Sell |
| 20-day SMA: | 0.08 | Sell |
| 50-day SMA: | 0.08 | Sell |
| 200-day SMA: | 0.08 | Sell |
| 8-day EMA: | 0.08 | Sell |
| 20-day EMA: | 0.08 | Sell |
| 50-day EMA: | 0.08 | Sell |
| 200-day EMA: | 0.35 | Sell |
Altamira Therapeutics Ltd. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 47.42 | Sell |
| Chaikin Money Flow: | -4684 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.07 - 0.09) | Sell |
| Bollinger Bands (100): | (0.06 - 0.1) | Sell |
Altamira Therapeutics Ltd. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Altamira Therapeutics Ltd. Stock
Is Altamira Therapeutics Ltd. Stock a Buy?
-
Altamira Therapeutics Ltd. share price is 0.08 while CYTOF 8-day simple moving average is 0.08, which is a Sell signal.
-
The stock price of CYTOF is 0.08 while Altamira Therapeutics Ltd. 20-day SMA is 0.08, which makes it a Sell.
-
Altamira Therapeutics Ltd. 50-day simple moving average is 0.08 while CYTOF share price is 0.08, making it a Sell technically.
-
CYTOF stock price is 0.08 and Altamira Therapeutics Ltd. 200-day simple moving average is 0.08, creating a Sell signal.
CYTOF Technical Analysis vs Fundamental Analysis
Sell
28
Altamira Therapeutics Ltd. (CYTOF)
is a Sell
Is Altamira Therapeutics Ltd. a Buy or a Sell?
-
Altamira Therapeutics Ltd. stock is rated a SellThe current Altamira Therapeutics Ltd. [CYTOF] share price is $0.08. The Score for CYTOF is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Altamira Therapeutics Ltd. Stock Info
Market Cap:
349.7K
Price in USD:
0.08
Share Volume:
4.7K
Altamira Therapeutics Ltd. 52-Week Range
52-Week High:
0.20
52-Week Low:
0.05
Sell
28
Altamira Therapeutics Ltd. (CYTOF)
is a Sell
Altamira Therapeutics Ltd. Share Price Forecast
-
What is the Altamira Therapeutics Ltd. stock price today?The Altamira Therapeutics Ltd. stock price is 0.08 USD today.
-
Will CYTOF stock go up or go down?Altamira Therapeutics Ltd.> share price is forecast to RISE/FALL based on technical indicators
-
Is Altamira Therapeutics Ltd. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Altamira Therapeutics Ltd. is overvalued.
Is Altamira Therapeutics Ltd. Stock a Buy?
-
Altamira Therapeutics Ltd. share price is 0.08 while CYTOF 8-day exponential moving average is 0.08, which is a Sell signal.
-
The stock price of CYTOF is 0.08 while Altamira Therapeutics Ltd. 20-day EMA is 0.08, which makes it a Sell.
-
Altamira Therapeutics Ltd. 50-day exponential moving average is 0.08 while CYTOF share price is 0.08, making it a Sell technically.
-
CYTOF stock price is 0.08 and Altamira Therapeutics Ltd. 200-day simple moving average is 0.35, creating a Sell signal.
Fundamental Analysis of Altamira Therapeutics Ltd.
Is Altamira Therapeutics Ltd. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.48 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Altamira Therapeutics Ltd.
Should I short Altamira Therapeutics Ltd. stock?
-
CYTOF Moving Average Covergence Divergence (MACD) indicator is 0, suggesting Altamira Therapeutics Ltd. is a Buy
-
Altamira Therapeutics Ltd. Relative Strength Index (RSI) is 47.42, which suggest Altamira Therapeutics Ltd. is oversold
-
The Bollinger Bands (25) for Altamira Therapeutics Ltd. is (0.07 - 0.09), which suggest Altamira Therapeutics Ltd. is a Sell
-
The Bollinger Bands (100) for Altamira Therapeutics Ltd. is (0.06 - 0.1), which suggest Altamira Therapeutics Ltd. is a Sell
* Altamira Therapeutics Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.